Skip to main content
. 2023 Jan 20;3:101714. doi: 10.1016/j.bas.2023.101714

Table 4.

The therapeutic measures against LBP.

MEASURES GROUP TIME
Base 3RD MONTH 9TH MONTH
No actiond CGa 51 (17.8) 88 (34.4) 144 (28.7)
IGa 70 (15.3) 104 (37.4) 138 (25.8)
Intervention effectb 1.43 (0.86–2.37) 1.07 (0.68–1.68)
Physician consultationd CGa 115 (40.1) 30 (11.7) 129 (25.7)
IGa 231 (50.5) 38 (13.7) 98 (18.4)
Intervention effectb 0.74 (0.41–1.36) 0.45c (0.30–0.68)
Imagingd CGa 76 (26.5) 8 (3.1) 74 (14.8)
IGa 142 (31.1) 23 (8.3) 33 (6.3)
Intervention effectb 1.69 (0.74–3.83) 0.32c (0.19–0.54)
Medicationd CGa 144 (50.2) 83 (32.4) 205 (40.9)
IGa 216 (47.3) 81 (29.1) 143 (26.8)
Intervention effectb 0.94 (0.60–1.49) 0.61c (0.41–0.90)
Surgeryd CGa 5 (1.7) 1 (0.4) 0 (0.0)
IGa 8 (1.8) 1 (0.4) 9 (1.7)
Intervention effectb
Home remediesd CGa 98 (34.1) 127 (49.6) 184 (36.7)
IGa 112 (24.5) 120 (43.2) 279 (52.2)
Intervention effectb 1.22 (0.81–1.86) 2.38 c (1.67–3.41)
a

Data are presented as: n (%).

b

Data are presented as: OR 95% CI (odds ratio, 95% confidence interval).

c

Statistically significant.

d

GEE model adjusted by baseline variables was used. Reference categories were time at baseline and control group.